I disagree on the notion that this is an incredibly expensive product for which we have no clue of the potential cost and that they are “sharing” profit with an outside firm. Also, Car-T is much more complex, expensive to make and still hand made. I think they have way more difficulties for now meeting potential demand, there are multiple approved similar products for the same narrow sliver of the oncology market with many more in the running, potentially with much better production technologies and yet they still were bought out for 10Billion.
I think you’re overstating the costs, dependencies and issues AHP, and the potential confusion for a much better market cap. I was in those Car-T companies, they were in the 4-6 Billion market cap even when one of them was halted for killing patients, still nowhere near approval, yet to figure out how to deal with it. I think their business is far less attractive than this one, where 2-3 years of vaccine is made all at once, there are limited side effects, the pricing per year is quite reasonable for a life extending, good quality of life cancer treatment and they have what looks like scalable, automated manufacturing likely coming on line in the bit too distant future, regardless of what our bulletin board experts might claim. Even so, with the hand made option, they can still make quite a bit, and the cost is set already by contract and is likely to decline, over time, on a per year basis, on scale up.
I don’t think it is unreasonable to expect a much higher market cap. The issues are macroeconomic. This burst to $2.51 long before TLD was likely in the picture, based on the buyout of the Flaskworks technology at a very reasonable price.
I think the market is doing its thing right now, many stocks are down, but too much “ambiguity” of ambiguous nature should not be thrown onto the normal ambiguities. The factory does belong to NWBO, the license to manufacture is fine where it is, but can be easily transferred to a buyer on purchase, as part of the existing contracts in this kind of an arrangement.
